Key result
Self-expanding apical closure device safely seals 21-Fr access in ~89% of minipigs without acute tamponade.
Why the study?
Available apical occluders do not fulfill requirements for full-percutaneous transapical valve procedures with large-sized introducer sheaths.
Is a self-expanding apical closure device safe and effective for sealing 21-Fr percutaneous apical accesses in a minipig model?
Is a self-expanding apical closure device safe and effective for sealing 21-Fr percutaneous apical accesses in a minipig model?
A novel self-expanding apical closure device successfully sealed large 21-Fr percutaneous apical accesses in a minipig model without significant thrombosis or embolization, supporting further development for closed-chest transapical procedures.
Answers are grounded in this paper and cite their sources.
Device seals large apical access in minipigs without acute complications; leaves open human safety and efficacy for transapical procedures.
OBJECTIVES: Available apical occluders do not fulfil requirements for full-percutaneous transapical valve procedures with large-sized introducer sheaths. A self-expanding closure device designed for closed-chest transapical valve procedures was tested in an animal model to verify safety, efficacy and thrombogenicity. METHODS: Large-sized 21-Fr introducer sheaths (Certitude™ system for Sapien™ valves) were percutaneously placed in the ventricles of nine 3-month old minipigs. To seal the apical access, delivery catheters carrying folded self-expanding plugs were inserted. Then, the plugs were deployed while sheaths were removed. Echocardiograms verified tamponade and cardiac function, drains were not placed and a 3-month long aspirin therapy was administered. After 6 and 9 months, animals were euthanized and organs were analysed for macroembolic lesions search. Histological analysis was also performed. RESULTS: Nine minipigs (weight: 28±3 kg) were used for this study. Eight plugs were successfully deployed in 8 ventricles without cardiac tamponade or ventricular dysfunction (success rate: 88.9%). In a failed procedure (the animal died after 1 month of cardiac tamponade), the outer disc of the apical plug got stuck in the intercostal space and did not correctly deploy. Post-mortem analysis in 8 minipigs at 6 (n = 4) and 9 months (n = 4) confirmed full deployment and good fixation of all plugs with internal surfaces covered by new endocardium. Macroscopic analysis of myocardium and vital organs showed absence of embolic lesions. Histological analysis showed absence of significant inflammatory infiltration and thrombosis. CONCLUSIONS: In this animal model, self-expanding closure devices sealed 21-Fr large percutaneous apical accesses without acute tamponade, thrombosis or embolization. Further tests to evaluate full-percutaneous closed-chest apical procedures are required.
No takes yet. Share an insight, caveat, or question.
Hong et al. (2019) studied Apical access closure (n=9). Self-expanding apical closure device was evaluated on Successful deployment without cardiac tamponade or ventricular dysfunction. A self-expanding apical closure device successfully sealed 21-Fr percutaneous apical accesses in 88.9% of minipigs without acute tamponade, thrombosis, or embolization.
Synapse has enriched 10 related papers. Consider them for comparative context: